Human Papillomavirus Genotype Distribution in Invasive Squamous Cell Carcinoma of the Uterine Cervix

来源 :The 6th Biennial Conference of Asia Oceania Research Organis | 被引量 : 0次 | 上传用户:zhenghao_w
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective To investigate the prevalence of human papillomavirus (HPV) and the HPV genotype distribution in invasive squamous cell carcinoma of the uterine cervix in the Mongolian women in inner Mongolia autonomy region.
其他文献
Objective: To evaluate the clinical significance of APTIMA human papillomavirus (AHPV) assay for detection of patients with cytological low grade squamous intraepithelial lesions (LSIL) and compare it
会议
HPV DNA tests have been applied in Jiangxi province where was famous for cervical cancer high incidence area in China.
Object: To investigate the prevalence of cervical cancer and precancerous lesions among women in eastern area of Inner Mongolia.
Objectives: Cost estimation plays a central role in the health economic analysis.This study was undertaken to estimate the per capita expenditure associated with cervical cancer (CC) screening and tre
Objectives: HPV 16 and 18 are the two most common HPV oncogenic types that are now preventable by vaccination.
Objectives: This study aimed at characterization of plasma protein profile and the interaction network common to cervical squamous cell carcinoma (CSCC) by proteomics approach, and the identification
Objectives: To investigate the optimal positive cutpoints of careHPV testing on clinician-and self-collected specimens in a large sample sized study.
会议
Objectives: To compare the consistency of HPV genotype and viral loads among different sites within the female genital tract, and to correlate these with clinical outcomes.Mehthods:2,646 previously un
Objectives: To evaluate the effectiveness of CO2 laser vaporization of vaginal intraepithelial neoplasia(VaIN) and vulvar intraepithelial neoplasia(VIN).
Objective: This study was to evaluate the clinical performance of APTIMA(R) human papillomavirus (AHPV) assay and Hybrid Capture 2 (HC2) test in the screening of cervical disease, especially in the wo